Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu, 41944, South Korea.
Department of Statistics, Kyungpook National University, Daegu, South Korea.
Sci Rep. 2022 Nov 3;12(1):18555. doi: 10.1038/s41598-022-16163-w.
Females are known to have a better survival rate than males in the general population, but previous studies have shown that this superior survival is diminished in patients on dialysis. This study aimed to investigate the risk of mortality in relation to sex among Korean patients undergoing hemodialysis (HD) or peritoneal dialysis (PD). A total of 4994 patients with kidney failure who were receiving dialysis were included for a prospective nationwide cohort study. Cox multivariate proportional hazard models were used to determine the association between sex and the risk of cause-specific mortality according to dialysis modality. During a median follow-up of 5.8 years, the death rate per 100 person-years was 6.4 and 8.3 in females and males, respectively. The female-to-male mortality rate in patients on dialysis was 0.77, compared to 0.85 in the general population. In adjusted analyses, the risk of all-cause mortality was significantly lower for females than males in the entire population (hazard ratio [HR] 0.79, 95% confidence interval [CI] 0.71-0.87, P < 0.001). No significant differences in the risk of cardiovascular and infection-related deaths were observed according to sex. The risk of mortality due to sudden death, cancer, other, or unknown causes was significantly lower for females than males in the entire population (HR 0.66, 95% CI 0.56-0.78, P < 0.001), in patients on HD (HR 0.75, 95% CI 0.62-0.90, P = 0.003), and in patients on PD (HR 0.49, 95% CI 0.34-0.70, P < 0.001). The survival advantage of females in the general population was maintained in Korean dialysis patients, which was attributed to a lower risk of noncardiovascular and noninfectious death.Trial registration: ClinicalTrials.gov Identifier: NCT00931970.
女性在普通人群中的生存率高于男性,但先前的研究表明,这种优势在接受透析治疗的患者中会降低。本研究旨在调查韩国接受血液透析(HD)或腹膜透析(PD)的患者中,性别与死亡率之间的关系。一项前瞻性全国队列研究共纳入了 4994 名接受透析治疗的肾衰竭患者。使用 Cox 多变量比例风险模型来确定性别与根据透析方式的特定原因死亡率之间的关联。在中位随访 5.8 年期间,女性和男性的死亡率分别为每 100 人年 6.4 和 8.3 人。与普通人群中的 0.85 相比,透析患者中的女性与男性的死亡率比为 0.77。在调整分析中,与男性相比,女性的全因死亡率风险在整个人群中显著降低(风险比 [HR] 0.79,95%置信区间 [CI] 0.71-0.87,P<0.001)。根据性别,未观察到心血管和感染相关死亡风险的差异。与男性相比,女性的全因死亡率风险显著降低,原因是突然死亡、癌症、其他或未知原因(HR 0.66,95%CI 0.56-0.78,P<0.001)、HD 患者(HR 0.75,95%CI 0.62-0.90,P=0.003)和 PD 患者(HR 0.49,95%CI 0.34-0.70,P<0.001)。女性在普通人群中的生存优势在韩国透析患者中得以维持,这归因于非心血管和非传染性死亡风险较低。试验注册:ClinicalTrials.gov 标识符:NCT00931970。